New UN report sees opportunities for better access to medicines in poor countries via investment in responsible local production
All components of this story
Author: Catherine Saez, Intellectual Property Watch [Switzerland]
Access to essential medicines in least developed countries (LDCs) could be facilitated through local production, according to a report released today by the United Nations Conference on Trade and Development...[M]ajor players in developed countries[are] facing the expiration of patents on some high-revenue drugs, and a shortage of new drugs to replace them...pushing those companies to seek partnerships with prominent generic manufacturers both in developed and in developing countries...[S]ome caution needs to be exercised, the report said...“[I]nvestors will need assurances by governments” that the basic prerequisites for the manufacture of high-quality medicines at low cost are present in the countries...The choice of medicines to be produced locally... needs to follow a public health perspective...technology transfer needs to be part of any investment in the local production or pharmaceuticals...
[PDF] Investment in Pharmaceutical Production in the Least Developed Countries: A Guide for Policy Makers and Investment Promotion Agencies
Author: UN Conference on Trade and Development
This guide outlines...recent trends, the basic prerequisites for the local production of pharmaceuticals and the key points that policymakers and investment negotiators especially from investment promotion agencies, will need to keep in mind in efforts to support this important sector...